1. Home
  2. CYN vs BGLC Comparison

CYN vs BGLC Comparison

Compare CYN & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cyngn Inc.

CYN

Cyngn Inc.

BUY

Current Price

$0.41

Market Cap

10.4M

Sector

Technology

ML Signal

BUY

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$1.19

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYN
BGLC
Founded
2013
2017
Country
United States
Malaysia
Employees
62
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
3.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
CYN
BGLC
Price
$0.41
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 192.7K
8.0K
Earning Date
11-17-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.78
EPS
N/A
★ N/A
Revenue
$368,138.00
★ $7,424,911.00
Revenue This Year
$424.72
N/A
Revenue Next Year
$596.26
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.44
$1.07
52 Week High
$5.09
$5.85

Technical Indicators

Market Signals
Indicator
CYN
BGLC
Relative Strength Index (RSI) 22.71 41.82
Support Level N/A $1.12
Resistance Level $1.76 $1.39
Average True Range (ATR) 0.05 0.08
MACD -0.01 -0.00
Stochastic Oscillator 1.36 25.12

Price Performance

Historical Comparison
CYN
BGLC

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: